Recent studies have demonstrated that several genetic alterations may be involved in tumour development in the colorectum (for review, see Fearon & Vogelstein, 1990) . A consistent observation is the loss or functional inactivation of several chromosome loci presumed to contain tumour suppressor genes. Loss of loci on chromosomes 5, 17 and 18, as well as mutations in the ras gene and the p53 gene have been reported (Muleris et al., 1985; Fearon et al., 1987; Vogelstein et al., 1988; Lothe et al., 1988; Okamoto et al., 1988; Law et al., 1988; Soussi et al., 1990; Baker et al., 1990) , and it has been demonstrated that these changes often appear in a sequential manner, paralleling the clinical advancement of the tumours (Vogelstein et al., 1988) .
The retinoblastoma (Rb) gene is located on chromosome band 13ql4.2. Loss or inactivation of this gene has been demonstrated in several human malignancies (for reviews, see Benedict et al., 1990; Marshall, 1991) . The Rb gene has been shown to suppress tumour development (Bookstein et al., 1990) , and the gene is therefore classified as a tumour suppressor gene. Little is known about the involvement of this gene in colorectal tumourigenesis. However, in a small series of colorectal carcinomas, it has recently been reported a significant amplification of the Rb gene (Gope et al., 1990) .
In DNA flow cytometric assays, the total DNA content of the main cell populations of tumours is quantified. Demonstration of an aneuploid DNA pattern reflects gross chromosomal changes, and may indicate genetic instability in the tumour cells (Rognum et al., 1983; Meling et al., 1991) . Furthermore, the presence of aneuploidy is an important prognostic variable in colorectal carcinomas (Wolley et al., 1982; Armitage et al., 1985; Rognum et al., 1987 .
In 255 colorectal carcinomas, we have studied Rb gene alterations using Southern (Lexow, 1989) . A minimum of 300 cells from each tumour were evaluated and classified as either tumour cells, mononuclear leukocytes, granulocytes, or cells of undetermined origin, according to standard cytological criteria (Koss, 1968) .
To evaluate intratumoural variation, two to five samples from each of eight carcinomas were analysed for DNA alterations.
Southern analysis
Nuclear DNA was extracted from both tumour cell suspensions and from peripheral blood leukocytes in a 340A Nucleic Extractor (Applied Biosystem, Rotterdam, The Netherlands), using standard methods (phenol-chloroform extraction and ethanol precipitation) (Kunckel et al., 1977 (Dukes, 1932; Turnbull et al., 1967) ; bAccording to the criteria ofthe WHO (Morson & Sobin, 1976) ; cAccording to standard cytological criteria (Koss, 1966) (Southern, 1975) , using alkaline solution (0.4 M NaOH and 0.6 M NaCl). Southern blots of RsaI digested DNA were hybridised with the probe p68RS2.0 which detects a variable number of tandem repeat (VNTR) region in an intron of the Rb gene (Wiggs et al., 1988) . As a control for a possible background level of DNA alterations, the Southern blots of PvuII and MspI digested DNA were hybridised with the VNTR probes pYNZ2, which maps to a sequence on chromosome lp, and pYNH24 which maps to a sequence on chromosome 2p (Nakamura et al., 1987) , respectively (Table II) .
The probes were radioactively labelled with [M32P]dCTP according to the random labelling method (Feinberg & Vogelstein, 1983) . Prehybridisations (2 h) and hybridisations (overnight) were carried out in 0.5 M NaHPO4, pH 7.2, 0.001 M EDTA, 7% Sodium Dodecyl Sulfate (SDS), and 1% Bovine Serum Albumin (BSA) at 65°C. After hybridisation, the filters were washed for 10-15 min at 65°C in a 0.04 M NaHPO4 solution, pH 7.2, containing 1% SDS. X-ray films (Kodak, XAR-5, Eastman Kodak Company, Rochester, NY, USA) were exposed to the radiolabelled filters for 1-7 days at -70°C using intensifying screens (Kodak).
Densitometric measurements and scoring criteria Densitometric measurements were performed on all the heterozygote cases using a Bio-Rad 1650 scanning densitometer. The membranes were rehybridised with an additional probe to adjust for differences in DNA loading (Table II) . When the ratio between the allele ratios of normal and tumour DNA was > 1.5, a significant change was scored. This ratio was chosen to be able to score a tumour with the change in question common for one-third or 50% (reduction or increase in hybridisation intensity, respectively) or more of the tumour cells (with regard to allelic amplification, assuming that the affected cells each had one extra copy of the DNA segment analysed). After adjustment for amount of DNA loaded, the genetic change was scored as either allelic amplification, when an increase in hybridisation intensity of one allele was observed, or loss of heterozygosity, when a reduction was observed (Figure 1 ).
Flow cytometric analysis
Flow cytometric analysis was performed on the ethanol fixed cell suspensions according to the method described by Crissman and Steinkamp (1982) , and modified by Kirkhus et al. (1988) . The cells were incubated with RNAase, 190 , Mannheim, Germany) , for 30 min in dark in 20°C, and thereafter stained with the fluorochrome propidium iodide, 17 lAg ml-(Sigma Chemical Co., St Louis, MO, USA), for 1 h on ice in dark. The emission of red fluorescence was measured in an Ortho Cytofluorograph 50H (Ortho Instruments, Westwood, MA, USA). Mouse spleen lymphocytes were used as an external diploid (2c) DNA control.
Definition of aneuploidy
The cellular amount of DNA was expressed as a DNA index (Hiddemann et al., 1984) . The DNA index is the ratio between the mean relative DNA content of the cell population examined and the mean DNA content of the diploid reference cells. The peak with the lowest DNA content was referred to as the diploid reference cell population . The mean coefficient of variation (CV) of the diploid peak was 3.2 (range 1.1-5.5). A tumour was defined as aneuploid ( Figure 2b ) if a second distinct population of G, cells was present, and had a DNA index> 1.10 (Kirkhus et al., 1988; Meling et al., 1991) . Otherwise the tumour was defined as near diploid (Figure 2a ). This definition is at variance with the definition of aneuploidy based on cytogenetic criteria, which defines tumours with any deviation from the exact multiple of the haploid chromosome number, as aneuploid (Thompson & Thompson, 1980) .
In the DNA histogram analysis, minor peaks at the 4c level ( Figure 2a ) may represent either G2 cells of the diploid GI population, or GI cells of a tetraploid (aneuploid) cell population, or a combination of the two. To differentiate between an aneuploid cell population with tetraploid DNA content and G2 cells of the diploid population in the DNA histograms, planimetry was used (G6hde, 1973) . When the area below the 4c peak was larger than the area between the 2c and 4c levels (S-phase), the 4c peak was considered to represent an aneuploid cell population. The rationale for this is that in proliferating mammalian cells, the proportion of cells in G2 phase is generally lower than that in the S-phase (Steel, 1977) .
Statistical analysis
For comparison between distributions, the x2 test was applied.
Results
Proportions of tumour cells and non-tumour cells The cell suspensions contained a mean of 84% tumour cells (range 62 to 97%) with a normal distribution among the 18 different samples analysed. The non-tumour cells comprised a mean of 9% mononuclear leukocytes (range 3 to 24%), 1 % granulocytes (range 0 to 4%), and 6% cells of undetermined origin (range 0 to 18%). The majority of the latter cells which had small and pycnotic nuclei, most likely represented tumour cells or small inflammatory cells. Tables III and IV) . The mean increase in hybridisation intensity of the amplified allele was 2.4-fold (range 1.5 to 4.2). Nine (5.8%) of the tumours with allelic amplification had lost the other allele. A total of 18 tumours (11.5%) had loss of one allele within the Rb locus (Figure 1 and Tables III and IV).
In the pYNZ2 locus on chromosome Ip, three of 180 carcinomas (1.7%) demonstrated allelic amplification, with increases in hybridisation intensity of 2.4, 3.8 and 4.0, respectively. One (0.6%) of these tumours had in addition loss of the other allele. A total of 40 tumours (22.2%) had heterozygous loss at this locus (Table III) .
In the pYNH24 locus on 2p, six of 236 tumours (2.5%) had amplification of one allele, of which three (1.2%) had lost the other allele. The mean increase in hybridisation intensity was 3.0-fold (range 1.6 to 5.8). At this locus, 37 tumours (15.7%) had loss of heterozygosity (Table III) .
The frequency of changes on chromosome lp and 2p were similar in tumours with changes in the Rb locus (n = 55) (Table IV) and in those without changes in the Rb locus (n = 101, individual data not shown) (X2 = 0.7, n.s. and X2= 0.05, n.s., respectively).
The frequency of allelic amplification was significantly higher within the Rb locus than on chromosomes lp and 2p, respectively (X2 = 51.9, P < 0.0001 and X2 = 59.3, P < 0.0001).
Similar frequencies of allelic loss were found within the Rb locus and at the locus on chromosome 2p (x2 = 1.3, n.s.). There were significantly more tumours with heterozygous loss on chromosome Ip than within the Rb locus (X2 = 6.7, P<0.01), and there tended to be more tumours with heter- Fearon & Vogelstein, 1990 The retinoblastoma gene acts as a tumour suppressor gene, and is known to be involved in several human malignancies (for reviews, see Benedict et al., 1990; Marshall, 1991) . In a cytogenetic study on colorectal carcinomas, a non-random gain of chromosome 13 has been demonstrated (Muleris et al., 1988) , and in a smaller colorectal carcinoma study, a significant amplification of the Rb gene was demonstrated both at the DNA and RNA levels (Gope et al., 1990) , both studies suggesting that the Rb gene may be involved in colorectal carcinogenesis. The findings of the latter report have recently been confirmed by Lothe et al. (1991) . Furthermore, loss of one chromosome 13 during development of a polyposis tumour has earlier been reported (Lothe et al., 1987) .
In our study of 255 colorectal carcinomas, we found genetic alterations within the Rb locus in 35.3% of the informative tumours. The majority of these tumours (46 of 55, 84%) had amplification of one allele, whereas only nine (16%) had heterozygous loss within the Rb locus without allelic amplification of the remaining allele. Our results therefore confirm that the Rb gene may be involved in colorectal carcinogenesis, and furthermore, that allelic amplification is the genetic change of importance.
In other malignancies with assumed involvement of the Rb gene in the tumourigenesis, loss of heterozygosity has been demonstrated, indicating a tumour suppressor gene activity of the Rb gene (Hansen & Cavenee, 1987) . Since heterozygous loss within the Rb gene does not occur more frequently than in random genes of chromosome 1 or 2, there seems to be no role for the Rb gene as a tumour suppressor gene in colorectal carcinomas. In the present study, however, we found that allelic amplification was by far the most common change within the Rb gene. Since amplification is a phenomenon known to be associated with some oncogenes, our results suggest that the Rb gene may have an oncogenelike effect in colorectal carcinomas. Another gene involved in colorectal tumourigenesis, the p53 gene located on chromosome 17, has previously been shown to be able to act both as a tumour suppressor gene as well as, in a mutated form, an oncogene (for review, see Levine, 1990) . Our demonstration of an increased copy number of a VNTR region within the Rb gene suggests that this region or the whole gene may be involved in local rearrangements, or that the carcinoma cells may contain increased copy numbers of large portions of chromsome 13. Preliminary data from our laboratory, however, indicate that amplification within the Rb locus does not commonly involve DNA sequences flanking the gene (data not shown), but indeed involves other DNA sequences within the gene itself (Lothe et al., 1991) . This makes it unlikely that the Rb gene is merely coamplified together with another possible oncogene located on chromosome 13. It has also recently been demonstrated that the DNA sequence detected by the VNTR probe p68RS2.0 contains possible hot spots for structural aberrations (T'Ang et al., 1989) . We have earlier reported a higher proportion of cells in the S-phase of the cell cycle in aneuploid carcinomas compared with near diploid ones Rognum et al., 1984) . In this study, we could demonstrate a significant association between amplification within the Rb gene and DNA aneuploidy. It has been assumed that both the Rb gene protein and p53 negatively regulate the passage of cells through the cell cycle (Mihara et al., 1989; Diller et al., 1990) . In aneuploid carcinomas, an amplified Rb gene may have an adverse effect, and enhance the number of cells that go through the S-phase, either directly, or indirectly through an interaction with and inactivation of p53.
Among the 57 aneuploid tumours informative at all three loci analysed, we could demonstrate only two carcinomas with DNA amplification on chromosomes lp and 2p, respectively. This suggest that the observed gain in total DNA content in aneuploid cells is not merely the result of random amplification of the diploid genome.
The frequency of heterozygous loss was higher on chromosome Ip than on chromosome 2p and within the Rb gene. This is in correspondence with the recently reported loss on chromosome lp in 42% of colon carcinomas (Leister et al., 1990) . Also, in several other solid tumours, heterozygous loss or cytogenetic deletions on chromosome lp has been associated with tumour development (Brodeur et al., 1981; Mathew et al., 1987; Trent et al., 1989) . In the present study, allelic loss on chromosome 1 was significantly associated with DNA aneuploidy. Therefore, loss of DNA sequences on chromosome 1 may be of importance for aneuploidy in a subset of aneuploid colorectal carcinomas.
In conclusion, our results suggest that the Rb gene is involved in colorectal carcinogenesis. As allelic amplification was found to be the most frequent change within the Rb locus, the mechanism for involvement of this gene is probably different in colorectal carcinomas compared with retinoblastomas. Our results also indicate that the increased amount of DNA present in aneuploid cell populations may constitute specific gene amplifications of importance in the colorectal carcinogenesis. Follow-up studies are already in progress to evaluate the possible prognostic significance of amplifications within the Rb gene in colorectal carcinomas.
